Recovery of immune cells after cord blood transplant
Part of Blood & lymphatic clinical trials.
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having your first cord blood transplant from an unrelated donor.
- You have a blood cancer or blood disorder that is treated with this type of transplant, such as acute leukemia, myelodysplastic syndrome, or severe aplastic anemia.
- You are willing and able to give written informed consent.
- You are not taking part in another trial that tests preventive donor cell infusions (like DLI or MSC) during this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether the time when stem cells are infused affects the chance of developing graft-versus-host disease (aGVHD) after a cord blood transplant. It may help find the best timing to improve outcomes for people with blood cancers.
This study tests whether a personalized nutrition plan (based on a prediction model) can improve recovery for adults receiving a stem cell transplant from umbilical cord blood.
This study tests giving you donated umbilical cord blood through an IV to help your body rebuild blood-forming cells after chemotherapy. It may help people who need a stem-cell “reset” using a specific type of cord blood unit that meets strict matching and safety rules.
This Phase 1/2 study tests whether a specific immune-cell “starter” injection (HTLP) can help adults rebuild their immune system faster after an umbilical cord blood transplant for blood cancers. It mainly focuses on safety and whether immune recovery improves.
This study looks at how the immune system rebuilds itself after a stem cell transplant. It may help doctors understand recovery better for people with blood cancers or other conditions needing a transplant.
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
Hear when a new Hematologic Disease and Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.